tiprankstipranks
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market

Petros Pharmaceuticals (PTPI) Ownership - Who Owns Petros Pharmaceuticals?

90 Followers

Petros Pharmaceuticals (PTPI) Ownership Overview

84.20%0.61%0.48%14.71%
84.20% Insiders
0.48% Other Institutional Investors
14.71% Public Companies and
Individual Investors
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail and individual investors. Approximately 1.09% of the company’s stock is owned by Institutional Investors, 84.20% is owned by Insiders and 14.71% is owned by Public Companies and Individual Investors.
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail and individual investors. Approximately 1.09% of the company’s stock is owned by Institutional Investors, 84.20% is owned by Insiders and 14.71% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
31,811Institution0.46%22,172
31,811Institution0.46%22,172
9,957Institution0.14%6,940

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
31,811Institution0.46%22,172
9,957Institution0.14%6,940

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
31,811Institution0.46%47,080

FAQ

Who Owns Petros Pharmaceuticals (PTPI)?
According to the latest TipRanks data, approximately 0.48% of the company's stock is held by institutional investors, 84.20% is held by insiders, and 14.71% is held by retail investors.
    What percentage of Petros Pharmaceuticals (PTPI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.48% of Petros Pharmaceuticals (PTPI) stock is held by institutional investors.
      What percentage of Petros Pharmaceuticals (PTPI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.71% of Petros Pharmaceuticals (PTPI) stock is held by retail investors.
        Who owns the most shares of Petros Pharmaceuticals (PTPI)?
        Vanguard owns the most shares of Petros Pharmaceuticals (PTPI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis